BIOMARIN PHARMACEUTICAL INC Insider Trading for November 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for November 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 15,000 | 397,350 | 35,225 | |
| Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 87.40 | 15,000 | 1,310,988 | 113,878 | 128.9 K to 113.9 K (-11.64 %) |
| Nov 29 2016 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 15,000 | 397,350 | 128,878 | 113.9 K to 128.9 K (+13.17 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,743 | 1,847,492 | 140,513 | |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,744 | 1,847,519 | 210,256 | |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.69 | 69,743 | 5,976,515 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,743 | 1,847,492 | 240,425 | 170.7 K to 240.4 K (+40.86 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.56 | 69,744 | 6,106,478 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
| Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,744 | 1,847,519 | 240,426 | 170.7 K to 240.4 K (+40.86 %) |
| Nov 22 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Option Exercise | M | 38.59 | 5,000 | 192,950 | 42,344 | |
| Nov 22 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Sell | S | 90.42 | 5,000 | 452,100 | 70,798 | 75.8 K to 70.8 K (-6.60 %) |
| Nov 22 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Buy | M | 38.59 | 5,000 | 192,950 | 75,798 | 70.8 K to 75.8 K (+7.06 %) |
| Nov 22 2016 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Gift | G | 0.00 | 360 | 0 | 70,798 | 71.2 K to 70.8 K (-0.51 %) |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,670 | 730,892 | 0 | |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.97 | 41,670 | 3,790,795 | 323,368 | 365 K to 323.4 K (-11.42 %) |
| Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,670 | 730,892 | 365,038 | 323.4 K to 365 K (+12.89 %) |
| Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 90.61 | 20,000 | 1,812,206 | 23,100 | 43.1 K to 23.1 K (-46.40 %) |
| Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 68.44 | 156 | 10,677 | 43,100 | 42.9 K to 43.1 K (+0.36 %) |
| Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 17.33 | 7,500 | 129,975 | 7,500 | |
| Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 95.00 | 7,500 | 712,500 | 13,860 | 21.4 K to 13.9 K (-35.11 %) |
| Nov 14 2016 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 17.33 | 7,500 | 129,975 | 21,360 | 13.9 K to 21.4 K (+54.11 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 140,000 | |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 210,000 | |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.83 | 70,000 | 5,797,806 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 70,000 | 1,505,700 | 393,368 | 323.4 K to 393.4 K (+21.65 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.52 | 70,000 | 5,776,435 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |
| Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 70,000 | 1,505,700 | 393,368 | 323.4 K to 393.4 K (+21.65 %) |